AS
Adam Schayowitz (EVP, Head of R&D) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Zymeworks Inc. (ZYME). The largest single filing was $358K of ZYME (13,832 sh × $25.85, as filed), executed Oct 9. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$358K
shares × price, as filed
Last traded
Oct 9
Filed Oct 9
Median ADV $18.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $358K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ZYME
Zymeworks Inc.
ZYME · 0 buys · 1 sell
1 filing
Recent filings
ZYMESALE
Zymeworks Inc.
View filing →
$358K13,832 sh × $25.85
Exec Oct 9
Filed Oct 9 · 6:28 PM ET